Why the study?
Is 24-hour urinary sodium excretion associated with serum aldosterone, plasma renin activity, and BNP levels in patients with diabetes?
Is 24-hour urinary sodium excretion associated with serum aldosterone, plasma renin activity, and BNP levels in patients with diabetes?
Low 24-hour urinary sodium excretion is associated with increased serum aldosterone in patients with diabetes, suggesting RAAS stimulation may be a mechanism contributing to adverse outcomes associated with low salt intake.
Answers are grounded in this paper and cite their sources.
Low salt intake may stimulate RAAS in diabetes; hypothesis-generating and requires prospective validation before clinical inference.
Although low dietary salt intake has beneficial effects on BP (blood pressure), low 24hUNa (24 h urinary sodium excretion), the most accurate estimate of dietary salt intake, is associated with increased mortality in people with diabetes. In the non-diabetic population, low salt intake is associated with increased RAAS (renin-angiotensin-aldosterone system) activity. In this cross-sectional study, we examined the relationship between 24hUNa, PRA (plasma renin activity), serum aldosterone and BNP (brain natriuretic peptide) in patients with diabetes. Clinical characteristics, 24hUNa, PRA, serum aldosterone and BNP were recorded in 222 consecutive patients (77% with Type 2 diabetes) attending a diabetes clinic at a tertiary hospital. The relationship between 24hUNa, serum aldosterone, PRA, BNP, urinary potassium excretion, serum potassium, serum sodium, eGFR (estimated glomerular filtration rate), urinary albumin excretion and HbA1c (glycated haemoglobin) was examined by a multivariable regression model. Levels of 24hUNa significantly predicted serum aldosterone in a linear fashion (R²=0.20, P=0.002). In the subgroup of patients (n=46) not taking RAAS-modifying agents, this relationship was also observed (R²=0.10, P=0.03), and the effect of 24hUNa on serum aldosterone was found to be more pronounced than in the whole cohort (coefficient=-0.0014, compared with -0.0008). There was no demonstrable relationship between 24hUNa and PRA or BNP. Low 24hUNa is associated with increased serum aldosterone in people with diabetes, in the presence and absence of RAAS-modifying agents. This raises the possibility that stimulation of the RAAS may be a mechanism that contributes to adverse outcomes observed in patients with low 24hUNa.
No takes yet. Share an insight, caveat, or question.
Libianto et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: